CIESSA

Welcome to the Brand page for “CIESSA”, which is offered here for Human pharmaceuticals, for the treatment of anti-viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, diabetes, hemostatic agents, infectious-related diseases, metabolic diseases, muscle dystonias, wrinkles and smooth muscle disorders, ophthalmic diseases and respiratory diseases;.

Its status is currently believed to be active. Its class is unavailable. “CIESSA” is believed to be currently owned by “Johnson & Johnson”.